Z-0216-2016 Class II Terminated

Recalled by ELITech Clinical Systems SAS — SEES, N/A

FDA device recall Z-0216-2016 was initiated by ELITech Clinical Systems SAS on Sep 22, 2015 and is designated Class II. Reason for recall: ELITech Clinical Systems reagents based on Trinder reaction used on the Selectra ProS and ProM systems are recalled due to potential drug interference. No complaints were received. The recall status is terminated (terminated Mar 4, 2016). Affected quantity: 969 systems.

Recall details

Product Type
Devices
Report Date
Nov 11, 2015
Initiation Date
Sep 22, 2015
Termination Date
Mar 4, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
969 systems

Product description

ELITech Clinical Systems reagents used on the Selectra ProS and ProM systems that utilize the Trinder Reaction method. The following product reference numbers and names: GPSL-025O: Glucose PAP SL AUML-0250: URIC ACID MONO SL CHSL-0250: CHOLESTEROL SL, TGML-0250: TRIGLYCERIDES SL, CRSL-0250: CREATININE PAP SL HDLL-0230: CHOLESTEROL HDL SL 2G LDLL-0230: CHOLESTEROL LDL SL 2G

Reason for recall

ELITech Clinical Systems reagents based on Trinder reaction used on the Selectra ProS and ProM systems are recalled due to potential drug interference. No complaints were received.

Distribution pattern

US Nationwide Distribution

Code information

all lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0216-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0216-2016. Report a data issue: hello@regdatalab.com.